About Us
Biorex Diagnostics was founded 20 years ago and has become a leading manufacturer of in vitro diagnostics.
We offer accurate, reliable products across multiple product ranges including; clinical chemistry, blood grouping, immunoassay ELISA and rapid testing. Using a global distributor network, Biorex products are available to hospitals, clinics, blood banks and research facilities in over 100 countries.
We are dedicated to developing market leading products and are committed to investing in the research and development of new products and collaborating with external research facilities and universities globally.
Our Products
Biorex Diagnostics have an extensive range of IVD products available across multiple categories including key example here, key example here & key example here.
Contact us for more information about our products & services
Become a Distributor
Over the past 20 years, Biorex has built a strong network of distributors that represent us in over 100 markets. We work with distributors to deliver accurate, reliable products, customer service and are happy to assist with marketing and additional requirements to maximise the potential of each distributor in their markets.
Interested in becoming a distributor? Complete a contact form and a member of our sales team will be in touch.
Latest News
-
National Diabetes Month 2022
National Diabetes Month 2022 Diabetes is a chronic disease characterised by insulin resistance either due to the pancreas’s inability to produce enough insulin or due to the body’s inability to use
-
The Role of Light Chains in Systemic Lupus Erythematosus (SLE)
The Role of Light Chains in Systemic Lupus Erythematosus (SLE) This year Biorex Diagnostics are celebrating Lupus Awareness Month, placing a focus on the most common form of lupus, systemic lupus
-
The Role of Lipoproteins in Atherosclerotic Cardiovascular Disease (ASCVD)
The Role of Lipoproteins in Atherosclerotic Cardiovascular Disease (ASCVD) Cardiovascular disease (CVD) is one of the leading causes of morbidity and mortality globally. Lipids and lipoproteins significantly contribute to atherosclerotic cardiovascular
-
Adverse Outcomes of SARS-CoV-2 Infection
Adverse Outcomes of SARS-CoV-2 Infection Caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, coronavirus disease 2019 (COVID-19) is a major public health burden which can be devastating 1.